Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,948 | -98,114 | 281,688 | -31,743 | -36,399 |
| Depreciation Amortization | -17,217 | -912 | 651 | 15,919 | 18,707 |
| Accounts receivable | -618 | N/A | 11,537 | 9,433 | 9,893 |
| Other Working Capital | -18,329 | -1,306 | -58,419 | -9,001 | 26,635 |
| Other Operating Activity | 4,311 | 79,707 | -333,184 | -123,129 | -10,471 |
| Operating Cash Flow | $-33,801 | $-20,625 | $-97,727 | $-138,521 | $8,365 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,955 | -36,355 | -5,449 | 7,171 | 1,867 |
| PPE Investments | -414 | -403 | -118 | 45,103 | -2,596 |
| Net Acquisitions | 9,796 | 4,135 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 0 | N/A | N/A | N/A | -33,000 |
| Other Investing Activity | 431 | 8,199 | 349,404 | 144,591 | -32,989 |
| Investing Cash Flow | $24,768 | $-24,424 | $343,837 | $196,865 | $-33,718 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 1,030 | 2,019 |
| Debt Repayment | -3,916 | -1,527 | -2,169 | -14,376 | -3,115 |
| Common Stock Issued | 228 | 130 | 4,387 | 9,050 | 930 |
| Common Stock Repurchased | 0 | -1,613 | -39,610 | N/A | N/A |
| Dividend Paid | N/A | N/A | -252,557 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -37,750 | 37,597 | -35 |
| Financing Cash Flow | $-3,688 | $-3,010 | $-327,699 | $33,301 | $-201 |
| Beginning Cash Position | 28,753 | 76,812 | 158,401 | 66,756 | 92,310 |
| End Cash Position | 16,032 | 28,753 | 76,812 | 158,401 | 66,756 |
| Net Cash Flow | $-12,721 | $-48,059 | $-81,589 | $91,645 | $-25,554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,801 | -20,625 | -97,727 | -138,521 | 8,365 |
| Capital Expenditure | -522 | -495 | -440 | -1,783 | -2,596 |
| Free Cash Flow | -34,323 | -21,120 | -98,167 | -140,304 | 5,769 |